Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 6 pages · Chinese
Xiamen Amoytop Biotech Co., Ltd. on 6ix
Earlier from Xiamen Amoytop Biotech
- Announcement on Amending Articles of Association and Some Governance Systems
- Announcement on the Chairman's Proposal to Repurchase Shares
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Voluntary Disclosure of a Wholly-owned Subsidiary Passing the High and New Technology Enterprise Certification
Later from Xiamen Amoytop Biotech
- Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Acceptance of Application for Issuing Convertible Corporate Bonds to Non-specific Objects by Shanghai Stock Exchange
Follow Xiamen Amoytop Biotech into a list and get an email when it puts out news.
Follow Xiamen Amoytop Biotech